| Literature DB >> 31726801 |
Aleksandra Maria Juszczak1, Marijana Zovko-Končić2, Michał Tomczyk1.
Abstract
Luteolin is a flavonoid often found in various medicinal plants that exhibits multiple biological effects such as antioxidant, anti-inflammatory and immunomodulatory activity. Commercially available medicinal plants and their preparations containing luteolin are often used in the treatment of hypertension, inflammatory diseases, and even cancer. However, to establish the quality of such preparations, appropriate analytical methods should be used. Therefore, the present paper provides the first comprehensive review of the current analytical methods that were developed and validated for the quantitative determination of luteolin and its C- and O-derivatives including orientin, isoorientin, luteolin 7-O-glucoside and others. It provides a systematic overview of chromatographic analytical techniques including thin layer chromatography (TLC), high performance thin layer chromatography (HPTLC), liquid chromatography (LC), high performance liquid chromatography (HPLC), gas chromatography (GC) and counter-current chromatography (CCC), as well as the conditions used in the determination of luteolin and its derivatives in plant material.Entities:
Keywords: chromatography; hyphenated techniques; luteolin
Mesh:
Substances:
Year: 2019 PMID: 31726801 PMCID: PMC6921003 DOI: 10.3390/biom9110731
Source DB: PubMed Journal: Biomolecules ISSN: 2218-273X
Figure 1Chemical structure of luteolin.
Recommended combinations of solvents / adsorbents for identification. of different flavonoid types by thin layer chromatography (TLC).
| Flavonoid Type | Adsorbent Type/Mobile Phase | ||
|---|---|---|---|
| Cellulose | Polyamide | Silica gel | |
| Polar flavonoid aglycones, e.g., flavones | BuOH:AcOH:H2O (3:1:1 | MeOH:AcOH:H2O | To:Py:FA (36:9:5 |
| Non-polar flavonoid aglycones, e.g., methylated flavones | 10–30% AcOH | --- | CHCl3:MEOH (15:1 to 3:1 |
| Flavonoid glycosides | BuOH:AcOH:H2O (3:1:1 | H2O:MeOH:MEK:methyl acetylacetone (13:3:3:1 | EtOAc:Py:H2O:MeOH (80:20:10:5 |
Abbreviations: AcOH, acetic acid; BuOH, butanol; CHCl3, chloroform; EtOAc, ethyl acetate; FA, formic acid; MeOH, methanol; MEK, methyl ethyl ketone; Py, pyridine; To, toluene. a The mobile phase is thoroughly mixed in the separating funnel and the upper phase is used. b The mobile phase is thoroughly mixed in the separating funnel and the excess water is discarded.
Thin layer chromatography in the analysis of luteolin derivatives.
| Luteolin Derivative | Stationary Phase | Mobile Phase | Detection | Analyzed Species | Ref. |
|---|---|---|---|---|---|
| Luteolin | silica gel 60 F254 | Hx:EtOAc:AcOH (31:14:5 | FBS; |
| [ |
| silica gel 60 RP-18 F254S | FA:H2O:MeOH (5.5:47.25:47.25 | ||||
| Luteolin 7-rutoside | silica gel | EtOAc:FA:AcOH:H2O (100:11:11:23 | NP/PEG, aniline phthalate; |
| [ |
| cellulose | 30% AcOH | ||||
| Luteolin 7-rhamnoside | polyamide | CHCl3:MeOH:MEK:AcAc (9:4:2:1 | |||
| Luteolin 3’-glucoside | silica gel 60 F254 | MeOH:H2O (15:5 | NP/PEG; |
| [ |
| Luteolin 6,8-dihexoside | |||||
| Luteolin 7-rutinoside |
| ||||
| Luteolin 7-glucoside | silica gel | EtOAc:FA:H2O (18:1:1 | NP/PEG; |
| [ |
| polyamide plates | EtOAc:FA:AcOH:H2O (100:10:10:13 | ||||
| Luteolin | silica gel 60 F254 | EtOAc:Ace:FA (8:1:1 | NP; |
| [ |
| Luteolin 7,4’-diglucoside | |||||
| Luteolin 6-hydroxy-7-glucoside | |||||
| Luteolin 4’-glucoside | |||||
| Luteolin 3’-glucoside | |||||
| Luteolin 7-glucoside | |||||
| Luteolin | silica gel 60 F254 | To:Et2O:AcOH (60:40:10 v/v/v); | NP/PEG; |
| [ |
| Luteolin 7-glucoside |
Abbreviations: AcAc, acetylacetone; Ace, acetone; AcOH, acetic acid; BuOH, butanol; CHCl3, chloroform; DI, 1,4-dioxane; Et2O, diethyl ether; EtOAc, ethyl acetate; FA, formic acid; FBS, Fast Blue B Salt; Hx, hexane; MeOH, methanol; MEK, methyl ethyl ketone; NP, 1% methanolic diphenylboric acid-β-ethylamino ester - natural product reagents; PEG, 5% ethanolic polyethylene glycol 4000; To, toluene; UV, ultraviolet spectroscopy; MS, mass spectrometry; NMR, nuclear magnetic resonance; IR, infrared.
High performance thin layer chromatography in the analysis of luteolin derivatives.
| Luteolin Derivative | Stationary Phase | Mobile Phase | Detection | Analyzed Species | Ref. |
|---|---|---|---|---|---|
| Luteolin | HPTLC silica gel 60 F254 | Hx:EtOAc:AcOH | FBS; |
| [ |
| HPTLC diol F254S | CHCl3:Hx:EtOAc (34:4 | 2% AlCl3; |
| [ | |
| HPTLC silica gel 60 | BuOH:MeOH:H2O | NPR/PEG; | |||
| HPTLC silica gel 60 F254 | EtOAc:MeOH:FA:H2O | MeOH:H2SO4 |
| [ | |
| HPTLC silica gel 60 F254 | To:EtOAc:FA | UV, 254 nm |
| [ | |
| HPTLC silica gel 60 F254 | DCM:MeOH | UV, 254 nm; |
| [ | |
| HPTLC silica gel G60 F254 | To:EtOAc:FA | UV, 349 nm |
| [ | |
| HPTLC silica gel 60 F254 | EtOAc:MeOH:H2O:AcOH | UV, 254, 366 nm | [ | ||
| HPTLC silica gel 60 F254 | To:EtOAc:FA | MeOH:H2SO4 |
| [ | |
| HPTLC silica gel 60 F254 | To:EtOAc:FA | NP/PEG; |
| [ | |
| HPTLC silica gel G60 F254 | To:EtOAc:FA | UV, 254, 366 nm |
| [ | |
| HPTLC silica gel 60 | NP/PEG; |
| [ | ||
| HPTLC silica gel 60 F254 | UV | Propolis | [ | ||
| HPTLC silica gel 60 GF254 | To:EtOAc:FA:MeOH | UV, 254, 365nm |
| [ | |
| HPTLC silica gel 60 F254 | To:EtOAc:FA | NP; |
| [ | |
| Luteolin 6-glucoside | HPTLC silica gel 60 F254 | EtOAc:FA:AcOH:H2O | NP/PEG; |
| [ |
| HPTLC silica gel 60 F254 | EtOAc:FA:H2O | NP/PEG; |
| [ | |
| Nano-DUASIL silica gel 60 | THF:To:FA:H2O | UV, 350 nm |
| [ | |
| Luteolin glucoside | HPTLC silica gel 60 F254 | EtOAc:FA:AcOH:H2O | NP/PEG; |
| [ |
| HPTLC silica gel 60 F254 | EtOAc:AcOH:FA:H2O | UV, 254, 366 nm |
| [ | |
| Luteolin | NP-HPTLC silica gel | EtOAc:FA:AcOH:H2O | H2O solution of 4% Al2(SO4)3; | [ | |
| To:EtOAc:AcOH | |||||
| HPTLC silica gel 60 F254 | To:EtFo:FA | NP; |
| [ | |
| Luteolin 7-glucoside | modified HPTLC silica gel 60 F254 with CN, NH2 | To:EtFo:FA | |||
| HPTLC diol F254 | EtOAc:MEK:DIPE:FA | ||||
| Luteolin 7-glucoside | HPTLC silica gel 60 | EtOAC:DCM:AcOH:FA:H2O | NP; |
| [ |
| HPTLC silica gel 60 F254 | EtOAc:AcOH:FA:H2O | NP/PEG; |
| [ | |
| Luteolin 7-rutinoside | HPTLC NH2 | Ace:AcOH | MeOH:AlCl3 (98:2 |
| [ |
| HPTLC RP-18W | H2O:MeOH | ||||
| Luteolin 7-glucuronide | HPTLC silica gel 60 | Et:Ace:H2O:FA | NP/PEG; |
| [ |
| Luteolin 7-glucoside | HPTLC NH2 | Ace:AcOH (85:15 | |||
| Luteolin 7-rutinoside | HPTLC NH2 | Ace:AcOH (85:15 | MeOH:AlCl3 (98:2 |
| [ |
| Luteolin 7-glucoside | |||||
| Luteolin 7-glucuronide | Ace:FA (85:15 | [ | |||
| HPTLC silica gel 60 | DIPE:Ace:H2O:FA (50:30:10:10 | ||||
| Luteolin | HPTLC silica gel 60 F254 | pre-develop: CHCl3:MeOH | NP: white light, 254, 366, 330 nm; |
| [ |
| Luteolin acetyl hexuronide |
| ||||
| Luteolin 7-rutinoside | |||||
| Luteolin acetyl hexoside | |||||
| Luteolin hexuronide | |||||
| Luteolin 3’,7-diglucoside | HPTLC silica gel 60 F254 | EtOAc:MeOH:AcOH:FA:H2O | NP; |
| [ |
| Luteolin 4’-glucoside | |||||
| Luteolin 7-glucoside | |||||
| Luteolin 8-glucoside | |||||
| Luteolin 6-glucoside | |||||
| Luteolin 8-glucoside | HPTLC RP C18 | FA:MeOH:H2O | ESI-MS/MS, |
| [ |
| HPTLC silica gel F254 | To:EtOAc:FA (6:5:1 |
Abbreviations: Ace, acetone; AcOH, acetic acid; AlCl3, aluminium trichloride; Al2(SO4)3, aluminium sulfate; BuOH, butanol; CHCl3, chloroform; DCM, dichloromethane; DI, 1,4-dioxane; DIPE, diisopropyl ether; ESI-MS/MS, electrospray ionization combined with tandem mass spectrometry; EtFo, ethyl formate; EtOAc, ethyl acetate; Et, ether; FA, formic acid; H2SO4, sulfuric acid; Hx, hexane; MeOH, methanol; MEK, methyl ethyl ketone; nHx, n-hexane; NP, 1% methanolic diphenylboric acid-β-ethylamino ester - natural product reagents; neurotransmitters; PEG, 5% ethanolic polyethylene glycol 4000; THF, tetrahydrofuran; To, toluene; UV-VIS, ultraviolet-visible spectroscopy; ESI-MS, electrospray ionization combined with mass spectrometry.
High performance liquid chromatography/ultra performance liquid chromatography in the analysis of luteolin derivatives.
| Luteolin Derivative | Stationary Phase/Column | Mobile Phase | Conditions | Detection | Analyzed Species | Ref. |
|---|---|---|---|---|---|---|
| Luteolin | ODS | 0.2% PA:H2O (A), MeOH (B) | injection volume: 20 μL; | DAD, 360 nm | Honey | [ |
| ODS C18 | 0.2% PA:H2O (58:41 | injection volume: 50 µL; | UV, 350 nm |
| [ | |
| Kinetex C18 | ACN (A), 0.05% TFA:H2O (B) | flow rate: 0.8 mL/min | UV, 254 nm |
| [ | |
| ODS Hypersil C18 | MeOH:ACN (1.25:1 | flow rate: 0.8 mL/min | MS |
| [ | |
| Zorbax SB-C18 | PA:H2O pH 4.0 (A), ACN (B) | injection volume: 50 µL; | DAD, 330 nm |
| [ | |
| ODS C18 | MeOH (A), 0.05% TFA:H2O (B) | injection volume: 20 μL; | UV, 280 nm |
| [ | |
| RP | 0.5% PA:H2O (A), ACN (B) | injection volume: 20 μL; | Triple-TOF-MS |
| [ | |
| RP C18 | 1% FA:H2O (A), | flow rate: 0.5 mL/min; | DAD-ESI-MS/MS | [ | ||
| Discovery HS C18 | 2% AcOH (A), ACN (B) | injection volume: 20 μL; | DAD |
| [ | |
| Ultrasphere 5 C18 | H2O (A), ACN (B) | injection volume: 10 μL; | ESI-MS; |
| [ | |
| Luteolin 6-glucoside | Vydac RP C18 | 0.05% TFA:H2O (A), 0.038% TFA:ACN ( | injection volume: 10 μL | UV, 342 nm |
| [ |
| Luteolin 8-glucoside | RP C18 | 0.5% FA:H2O (A), ACN (B) | injection volume: 20 µL; | DAD, 254, 340 nm |
| [ |
| Luteolin 7-glucoside | Hypersil gold C18 | 0.1% FA:H2O (A), 0.1% FA:MeOH (B) | injection volume: 10 µL; | MS |
| [ |
| Thermo C18 | 0.3% FA:H2O (A), ACN (B) | injection volume:10 μL; | DAD-Q- |
| [ | |
| Luteolin | Eclipse XDB C18 | 0.025% AcOH:H2O (A), 5% Ace:ACN (B) | 30 °C | ESI-MS/MS | [ | |
| Luteolin 7-glucoside | Eclipse XDB C18 | 1% PA:H2O (A), ACN (B) | injection volume: 10 μL; | DAD-ESI-QTOF-MS/MS |
| [ |
| Luteolin 7-rutinoside | Eclipse XDB C18 | ACN (A), 0.2% FA (B) | flow rate: 0.3 mL/min; | DAD, 230, 254, 290, 334 nm; |
| [ |
| Luteolin 7-rhamnoside | ||||||
| Luteolin | Gemini C18 | 0.5% AcOH:H2O (A), ACN (B) | 25 °C | ESI-QTOF-MS |
| [ |
| Luteolin 7,4-diglucoside | ||||||
| Luteolin 7-rutinoside | ||||||
| Luteolin 4-glucoside | ||||||
| Luteolin 3-glucoside | ||||||
| Luteolin 7-glucoside | ||||||
| Luteolin 6-glucoside | Spherisorb S5 ODS-2 | 5% FA:H2O (A), MeOH (B) | flow rate: 1 mL/min | DAD, 280 nm |
| [ |
| Luteolin 7 | ||||||
| Luteolin 7-glucoside | ||||||
| Luteolin 6-glucosyl-8-arabinoside | ||||||
| Luteolin 2’’-feruloylhexosyl-6-hexoside | Spherisorb S3 ODS-2 C18 | 0.1% FA:H2O (A), ACN (B) | flow rate: 0.5 mL/min; | DAD-MS; |
| [ |
| Luteolin 6-glucoside | ||||||
| Luteolin | Kinetex 100 C18 | 1% FA:H2O (A), 1% FA:ACN (B) | flow rate: 1 mL/min; 30 °C | ESI-QTOF-MS; |
| [ |
| Luteolin 7-rutinoside | ||||||
| Luteolin 3-glucuronide | ||||||
| Luteolin 3’-(2’’-acetyl)-glucuronide | Superschera 100 RP C18 | DAD, 324 nm | ||||
| Luteolin 6-hydroxy-7-glucoside | ||||||
| Luteolin hexosyl-hexoside-malylester | AquasilW C18 | TFA solution (pH 2.8) (A), ACN (B) | flow rate: 1.0 mL/min; | UV/DAD, 340 nm |
| [ |
| Luteolin 6-glucosyl-7-galactoside | ||||||
| Luteolin 6-glucosyl-7-rutinoside | ||||||
| Luteolin 6-glucosyl-7-rhamnosyl-galactoside | ||||||
| Luteolin 7-apiofuranosyl (1→2)-glucopyranoside | Eclipse Plus C18 | 0.1% FA:MeOH (A), 0.1% FA:H2O (B) | injection volume: 10 μL; | QTOF-MS/MS |
| [ |
| Luteolin 7-glucopyranoside | ||||||
| Luteolin 7-[apiofuranosyl (1→2)-(6’’-malony)]-glucopyranoside | ||||||
| Luteolin 7-(6-rhamnosyl)hexoside | Kinetex C18 | 1% FA (A), ACN (B) | injection volume: 8 μL; | DAD-ESI-MS; 340 nm |
| [ |
| Luteolin 7-(2-rhamnosyl)hexoside | ||||||
| Luteolin 7-(2-hexosyl[6-sulfate])hexoside | ||||||
| Luteolin 7-hexosyl(6-sulfate) | ||||||
| Luteolin | Gemini C18 | 0.1% FA:H2O (A), 0.1% FA:ACN (B) | 0-60 min, 10–60% B; | DAD-ESI-MS/MS; |
| [ |
| Luteolin 7-glucoside | ||||||
| Luteolin 7-glucoside | Synergy Polar RP 80Å, | 0.9% FA:0.1% AcOH:1.5% BuOH:H2O (A), | injection volume: 5 μL; | PAD; |
| [ |
| Luteolin 7,4’-diglucoside | ||||||
| Luteolin 6-hydroxy-7-glucoside | ||||||
| Luteolin 4’-glucoside | ||||||
| Luteolin 3’-glucoside | ||||||
| Luteolin 7-diglucuronide | Eclipse Plus C18 | 1% FA:H2O:ACN (A), ACN (B) | injection volume: 20 μL; | DAD; UV-VIS, 190-450 nm; |
| [ |
| Luteolin 5-rutinoside | Luna C18 | 0.1% FA:H2O (A), ACN (B) | injection volume: 5 μL; | DAD, 200-400 nm; |
| [ |
| Luteolin 7-rutinoside | ||||||
| Luteolin diglucoside | Luna C18 | 1% FA:H2O (A), ACN (B) | injection volume: 20 μL; | PDA-ESI-MS/MS |
| [ |
| Luteolin 7-rutinoside | ||||||
| Luteolin 7 | ||||||
| Luteolin | Gemini RP C18 | 2% AcOH:H2O (A), ACN (B) | --- | ESI-MS; |
| [ |
| Luteolin 2’’-Galloyl-4’-glucoside | ||||||
| Luteolin 4’-glucoside | ||||||
| Luteolin 6-methoxy-8-arabinosyl-7-glucoside | Symmetry Shield Waters RP18 | 0.2% FA:H2O (A), ACN (B) | flow rate: 1.2 mL/min | UV/PAD-MS; UV; |
| [ |
| Luteolin 8-glucoside | Symmetry Shield RP18 | UV/PAD | ||||
| Luteolin 8-rhamnosyl-7-rhamnoside | ||||||
| Luteolin 8-glucoside | Kinetex PFP | 0.8% AcOH:H2O (A), | injection volume: 10 μL; | UV/DAD, 330 nm |
| [ |
| Luteolin | Eclipse XDB C18 | MeOH (A), 0.2% FA:H2O (B) | flow rate: 0.8 mL/min; | DAD-MS/MS; |
| [ |
| Luteolin 7-glucoside | ||||||
| Luteolin 7-glucuronyl-3-glucoside | ||||||
| Luteolin 6-glucoside | ||||||
| Luteolin 6-glucosyl-2’’-rhamnoside | ||||||
| Luteolin 6-glucosyl-4’-glucoside | ||||||
| Luteolin 3’-glucoside | ||||||
| Luteolin hexosyl-rhamnoside | Spherisorb S3 ODS-2 C8 | 0.1% FA:H2O (A), ACN (B) | flow rate: 0.5 mL/min; | DAD-MS; |
| [ |
| Luteolin 7-rutinoside | ||||||
| Luteolin 7-glucoside | ||||||
| Luteolin | XDB C18 | 1% FA:H2O (A), ACN (B) | injection volume: 100 µL; | NMR; |
| [ |
| Luteolin 6-glucosyl-8-arabinoside | ||||||
| Luteolin 7-glucoside | ||||||
| Luteolin 6-arabinosyl-8-glucoside | ||||||
| Luteolin 3-glucopyranoside | PLRP-S 100Å | 0.1% FA:H2O (A), ACN (B) | injection volume: 100 µL; | MS |
| [ |
| Luteolin 7-glucopyranoside | ||||||
| Luteolin 7-rutinoside | ||||||
| Luteolin methoxy-hexoside | ||||||
| Luteolin 4’-glucopyranoside | XDB C18 | 1% FA:H2O (A), ACN (B), | injection volume: 100 µL; | |||
| Luteolin 6-hydroxy-7-glucoside | Gemini C18 | 0.1% FA:H2O (A), | flow rate: 0.8 mL/min | UV-VIS, 200-400 nm; |
| [ |
| Luteolin | Syncronis C18 | 0.1% AcOH:H2O (A), ACN (B) | injection volume: 5 μL; | DAD-MS/MS | Honey | [ |
| Luteolin 7-rhamnoside | ||||||
| Luteolin | HSS T3 | 0.1% FA:H2O (A), 0.1% FA:ACN (B) | injection volume: 3.1 µL; | PDA-MS |
| [ |
| Luteolin rhamnosyl hexoside | ||||||
| Luteolin rhamnosyl dihexoside | ||||||
| Luteolin diglucuronide | S3 ODS-2 C18 | 0.1% FA:H2O (A), ACN (B) | flow rate: 0.5 mL/min; | DAD-ESI-MS; |
| [ |
| Luteolin 7-glucuronide | ||||||
| Luteolin 7-rutinoside | ||||||
| Luteolin 7-glucoside |
| |||||
| Luteolin 6-glucoside |
| |||||
| Luteolin | Kinetex C18 | ACN (A), 0.1% FA:H2O (B) | injection volume: 10 μL; | ESI-MS |
| [ |
| Luteolin rutinoside | ||||||
| Luteolin hexoside | ||||||
| Luteolin 6-hexoside |
| |||||
| Luteolin 7-glucoside | Luna C18 | 5% FA:H2O (A), MeOH (B) | injection volume: 100 µL; | DAD, 200, 600 nm |
| [ |
| Luteolin hexuronide | 0.1% FA:H2O (A), MeOH (B) | injection volume: 10 µL; | ESI-MS/MS | |||
| Luteolin | Eclipse Plus C18 | 0.5% AcOH:H2O (A), ACN (B) | injection volume: 5 µL; | DAD-QTOF-MS; |
| [ |
| Luteolin hexosyl-pentoside | ||||||
| Luteolin 6-glucoside | ||||||
| Luteolin 8-glucoside | ||||||
| Luteolin 7-glucoside | ||||||
| Luteolin (3-hydroxy-3-methylglutaroyl)-X’’-deoxyhexosyl-hexoside | ODS-2 C18 with ODS-2 C18 guard cartridge | 1% FA:H2O (A), MeOH (B) | flow rate: 0.2 mL/min; | PDA-ESI-MS |
| [ |
| Luteolin 6-hexoside | ||||||
| Luteolin 6-rutinoside | ||||||
| Luteolin dihexoside | ||||||
| Luteolin | Syncronis C18 | 0.01% AcOH:H2O (A), ACN (B) | inaction volume: 5 μL; | MS |
| [ |
| Luteolin 6,8-dihexoside | ||||||
| Luteolin 6-hexosyl-8-pentoside | ||||||
| Luteolin 6-pentosyl-8-hexoside | ||||||
| Luteolin 6-hexoside | ||||||
| Luteolin 8-hexoside | ||||||
| Luteolin 7-(2’’-pentosyl-4’’-hexosyl)hexoside | ||||||
| Luteolin 7-(2’’-pentosyl)hexoside | ||||||
| Luteolin 7-glucoside | ||||||
| Luteolin 7-[2’’-(5’’’-sinapoyl)pentosyl]hexoside | ||||||
| Luteolin 7-(2’’-pentosyl-4’’-hexosyl- | ||||||
| Luteolin 7-(2’’-pentosyl-6’’-malonyl) | ||||||
| Luteolin 7-[2’’-(5’’’-sinapoyl)pentosyl- | ||||||
| Luteolin | Purospher star C18 | 10% FA:H2O (A), | 25 °C | DAD-ESI-MS; |
| [ |
| Luteolin 6,8-diglucoside | ||||||
| Luteolin 8-glucoside | ||||||
| Luteolin 7-rutinoside | ||||||
| Luteolin | Zorbax SB-C18 | AFNH4:H2O:ACN:FA (A), AFNH4:H2O:ACN:FA (B) | injection volume: 5µL; | ESI-MS; |
| [ |
| Luteolin 7 | ||||||
| Luteolin 7-rutinoside | ||||||
| Luteolin 7-glucoside | Beta-Basic C18 | 5% FA:ACN (A); 5% FA:H2O (B) | injection volume: 20 µL; | UV, 280 nm |
| [ |
| Luteolin 7-glucuronide |
| |||||
| Luteolin 7-rutinoside | ||||||
| Luteolin | UPLC BEH C18 and a Acquity UPLC BEH C18 VanGuardTM pre-column | 0.1% AcOH:H2O (A), | injection volume: 5 µL; | DAD-ESI-QTOF-MS; |
| [ |
| HSS T3 | 0.1% FA:H2O (A), 0.1% FA:ACN (B) | injection volume: 3 µL; | IMS-QTOF-MS | [ | ||
| Luteolin hexoside | Hypersil Gold C18 | 0.1% FA:H2O (A), ACN (B) | --- | DAD-ESI-MS |
| [ |
| Luteolin hydroxy-glucuronide | ||||||
| Luteolin 7-glucoside | ||||||
| Luteolin 7-glucuronide | ||||||
| Luteolin malonyl-hexoside | ||||||
| Luteolin glucuronide | ||||||
| Luteolin glucoside | flow rate: 0.2 mL/min | [ | ||||
| Luteolin rutinoside | ||||||
| Luteolin 7-rhamnosyl(1-6)galactoside | Eclipse XDB-C18 | 0.1% FA:H2O (A), 0.1% FA:ACN (B) | flow rate: 0.5 mL/min; | MS |
| [ |
| Luteolin 4’-glucuronide | C18μ-Bondapak RP18 | MeOH:H2O (42:58 | flow rate: 2.0 mL/min | NMR |
| [ |
| Luteolin | Kinetex 100 A C18 | 1% FA:H2O (A), ACN (B) | injection volume: 5 µL; | DAD, 340 nm |
| [ |
| Luteolin 3’-7-diglucoside | ||||||
| Luteolin 7-glucoside | ||||||
| Luteolin 6-(2-rhamnosyl)-hexoside | DAD-ESI-MS/MS; | |||||
| Luteolin (pentosyl)-hexoside | ||||||
| Luteolin hexoside | ||||||
| Luteolin 6-glucoside | ODS2 C8 | 0.1% FA:H2O (A), ACN (B) | flow rate: 0.5 mL/min; | DAD-ESI-MS; |
| [ |
| Luteolin 6-hexosyl-8-pentoside | S3 ODS-2 C18 | 0.1% FA:H2O (A), ACN (B) | flow rate: 0.5 mL/min; | DAD-MS; |
| [ |
| Luteolin 2’’-deoxyhexosyl-6-glucoside | ||||||
| Luteolin 6-glucoside | ||||||
| Luteolin 6-pentosyl-8-pentoside | ||||||
| Luteolin-7-rhamnoside | ||||||
| Luteolin 7-glucoside | ||||||
| Luteolin 2’’-deoxyhexosyl-pentoside | ||||||
| Luteolin 6-pentoside | ||||||
| Luteolin 2’’-deoxyosyl-6-(6-deoxy- | ||||||
| Luteolin | C18 | 0.005 % FA:H2O (A), MeOH (B) | injection volume: 10 µL; | MS-Orbitrap |
| [ |
| Luteolin 8-glucoside | ||||||
| Luteolin 4’-glucoside | ||||||
| Luteolin 7-glucoside | ||||||
| Luteolin 6-glucoside | ||||||
| Luteolin 6-glucoside | HSS T3 | 0.1% FA:H2O (A), 0.1% FA:ACN (B) | injection volume: 3.1 μL; | PDA-MS |
| [ |
| Luteolin 8 | ||||||
| Luteolin 6-deoxyhexosyl-8-pentoside | ||||||
| Luteolin 6-fucoside | ||||||
| Luteolin 8-deoxyhexoside | ||||||
| Luteolin 6,8-diglucoside | ||||||
| Luteolin 6,8-diglucoside | Kinetex C18 | 0.05% FA:H2O (A), 0.05% FA:ACN (B) | flow rate: 0.4 mL/min; | MS/MS |
| [ |
| Luteolin 8-glucosyl-7-glucoside isomer | ||||||
| Luteolin 6-glucosyl-7-glucoside isomer | ||||||
| Luteolin 8-glucosyl-7-rhamnoside | ||||||
| Luteolin 8-glucoside | ||||||
| Luteolin 7-glucoside | ||||||
| Luteolin 7-rhamnoside | ||||||
| Luteolin 7-(6’’-syringly)glucosyl-6-glucoside | ||||||
| Luteolin 7-(2’’-syringyl)arabinosyl-6 | ||||||
| Luteolin 8-(6’’-diacetyl)glucoside | ||||||
| Luteolin | Nucleosil 100-3.5 C18 | FA:H2O (A), FA:ACN (B) | injection volume: 20 µL | MS |
| [ |
| Luteolin 6-glucoside | ||||||
| Luteolin 6-[6’’-glocosy-caffeoyl-glucopyranosyl(’’→2)-glucopyranoside | Eclipse Plus C18 | 0.2% FA:H2O (A), 0.2% FA:ACN (B) | 30 °C | PDA-ESI-MS/MS |
| [ |
| Luteolin 6-glucopyranoside | UV, 350 nm | |||||
| Luteolin 7-glucoside | Syncronis C18 | 0.1% FA:H2O (A), ACN (B) | injection volume: 5 μL; | MS/MS |
| [ |
| Luteolin 6-glucoside | ||||||
| Luteolin 7-(2’’- | ||||||
| Luteolin | Luna Omega Polar C18 with Polar C18 Security Guard cartridge | 0.1% FA:H2O (A), ACN (B) | flow rate: 0.4 mL/min | ESI-MS/MS; |
| [ |
| Luteolin hexoside | ||||||
| Luteolin | Intersil ODS | ACN:H2O:FA (10:89:1 | injection volume: 10 µL; | DAD-MS/MS; |
| [ |
| Luteolin glucoside | ||||||
| Luteolin glucuronide | ||||||
| Luteolin pentosyl-glucoside | ||||||
| Luteolin 4’-glucoside | Kinetex RP C18 | PA:H2O pH 3 (A), PA:ACN pH 3 (B) | injection volume: 1 µL; | UV |
| [ |
| Luteolin 7- | C18 | 0.02% TFA:H2O (A), | injection volume: 2.5 µL; | DAD-ESI-MS |
| [ |
| Luteolin glucoside | YMC-Triart C18 | 0.1% FA:H2O (A), 0.1% FA:ACN B) | injection volume: 10 µL; | DAD-ESI-MA |
| [ |
| Luteolin 7- | ||||||
| Luteolin glucuronide | ||||||
| Luteolin malonylglucoside | ||||||
| Luteolin | ||||||
| Luteolin 7-diglucuronide | Eclipse XDB C18 | 0.03% PA:H2O (A), | injection volume: 20 μL; | DAD, 210, 250, 320, 350 and 370 nm |
| [ |
| Luteolin 7- |
Abbreviations: Ace, acetone; AcOH, acetic acid; ACN, acetonitrile; AFNH4, ammonium formate; BuOH, butanol; DAD, diode array detector; DAD-ESI-MS, diode array detector combined with electrospray ionization and mass spectrometry; DAD-ESI-MS/MS, diode array detector combined with electrospray ionization and tandem mass spectrometry; DAD-ESI-QTOF-MS, diode array detector combined with electrospray ionization and quadrupole – time of flight mass spectrometry; DAD-MS, diode array detector combined with mass spectrometry; DAD-MS/MS, diode array detector combined with tandem mass spectrometry; DAD-QTOF-MS, diode array detector combined with quadrupole – time of flight mass spectrometry; ESI-IT-MS/MS, electrospray ionization combined with ion trap and tandem mass spectrometry; ESI-MS, electrospray ionization combined with mass spectrometry; ESI-MS/MS, electrospray ionization combined with tandem mass spectrometry; ESI-QTOF-MS, electrospray ionization combined with quadrupole – time of flight mass spectrometry; FA, formic acid; IMS-QTOF-MS, ion-mobility spectrometry combined with quadrupole – time of flight mass spectrometry; MeOH, methanol; MS/MS, tandem mass spectrometry; PA, phosphoric acid; PAD, pulsed amperometric detection; PDA-ESI-MS/MS, pulsed amperometric detection combined with electrospray ionization and tandem mass spectrometry; PDA-ESI-MS, pulsed amperometric detection combined with electrospray ionization and mass spectrometry; PDA-MS, pulsed amperometric detection combined with mass spectrometry; TFA, trifluoroacetic acid; UV/PAD-MS, UV/pulsed amperometric detection combined with mass spectrometry.
Liquid chromatography in the analysis of luteolin derivatives.
| Luteolin Derivative | Stationary Phase | Mobile Phase | Conditions | Detection | Analyzed Species | Ref. |
|---|---|---|---|---|---|---|
| Luteolin | Zorbax SB C18 column with Security-Guard C18 | MeOH (A), 0.5% AcOH:H2O (B) | flow rate: 1.0 mL/min; | MS/MS |
| [ |
| Inertsil ODS-3 | 0.1% FA:H2O (A), ACN (B) | flow rate: 0.5 mL/min; | MS/MS |
| [ | |
| RP C18 | 0.1% FA:H2O (A), 0.1% FA:ACN (B) | injection volume: 5 µL; | ESI-MS/MS |
| [ | |
| Luteolin 7-glucoside | Eclipse XDB C18 | 1% FA:H2O (A), MeOH (B) | injection volume: 5 mL; | MS/MS |
| [ |
| Luteolin | Zorbax Plus C18 | 0.1% FA:H2O (A), 0.1% FA:ACN (B) | injection volume: 1µL; | MS |
| [ |
| Eclipse XDB C18 | 0.05% FA:H2O (A), MeOH (B) | flow rate: 1 mL/min | MS/MS |
| [ | |
| Luteolin 7-apiosyl-glucoside | Symmetry C18 | 0.1% FA:H2O (A), 0.1% FA:ACN (B) | flow rate: 1.0 mL/min; | DAD-ESI-MS; |
| [ |
| Luteolin 7-glucoside | ||||||
| Luteolin 7-malonyl-apiosyl-glucoside | ||||||
| Luteolin 7-6’-malonyl-apiosyl-glucoside | ||||||
| Luteolin 7-6’-malonyl-glucoside | ||||||
| Luteolin 3’-glucoside | Zorbax SB C18 | 0.1% FA:H2O (A); 0.1% FA:ACN (B) | injection volume: 5 μL; | MS/MS; TQMS; ESI |
| [ |
| Luteolin 6-glucoside | ||||||
| Luteolin 6,8-dihexoside | ||||||
| Luteolin 7-rutinoside |
| |||||
| Luteolin 7-rutinoside | XTerra MS C18 | ACN (A), 0.05% AcOH:H2O (B) | injection volume: 20 μL; | PDA-MS; NMR |
| [ |
| Luteolin 7-glucopyranoside | ||||||
| Luteolin | Octadecyl silica gel ODS | H2O:MeOH:FA (89:10:1 | flow rate: 1 mL/min; | MS/MS |
| [ |
| Luteolin glucuronide | ||||||
| Luteolin glucoside | ||||||
| Luteolin | Capcell Park C18 | 0.5% FA:H2O (A), 0.5% FA:ACN (B) | flow rate: 0.5 mL/min; | MS/MS |
| [ |
| Luteolin dihexoside | ||||||
| Luteolin 7-dihexoside | ||||||
| Luteolin 7-rutinoside | ||||||
| Luteolin glucoside | ||||||
| Luteolin 7-acetylglucoside | ||||||
| Luteolin 6-glucoside | Intersil ODS | ACN:H2O:FA (10:89:1 | flow rate: 0.7 mL/min; | MS/MS |
| [ |
| Luteolin glucoside | ||||||
| Luteolin methoxy-2’’-pentosyl-6-hexoside | ODS2 C8 | 0.1% FA:H2O (A), ACN (B) | flow rate: 0.5 mL/min; | DAD-ESI-MS; |
| [ |
| Luteolin 2’’-rhamnosyl-6’’-hexosyl-glucoside | ||||||
| Luteolin 7-glucosyl-8-glucoside | ||||||
| Luteolin 6-glucoside | ||||||
| Luteolin 6-hexosyl-8-pentoside | ||||||
| Luteolin acetylhexoside | Spherisorb S3 ODS2 C18 | 0.1% FA:H2O (A), ACN (B) | flow rate: 0.5 mL/min; | DAD-ESI-MS/MS |
| [ |
| Luteolin 6-glucoside | ||||||
|
| [ | |||||
| Luteolin 3-glucuronide |
| [ | ||||
| Luteolin glucuronide | ||||||
| Luteolin hexosyl-pentoside | Zorbax RP C18 | 0.1% FA:H2O (A), 0.1% FA:ACN (B) | injection volume: 5 μL; | QTOF |
| [ |
| Luteolin 7-glucoside | ||||||
| Luteolin 7-hexoside | ||||||
| Luteolin 6-hexoside | ||||||
| Luteolin 8-glucoside | ||||||
| Luteolin 6-hexosyl-8-acetyl-hexoside | ODS2 | H2O:ACN:FA | injection volume: 20 μL; | MS/MS |
| [ |
| Luteolin 8-glucosyl-7,3’-dimethoxyl- | ||||||
| Luteolin 8-glucosyl-7,3’-dimethoxyl- | ||||||
| Luteolin 6-glucoside | Hydro RP | H2O (A), MeOH (B), | flow rate: 1 mL/min | MS/MS |
| [ |
| Luteolin 8 | ||||||
| Luteolin | Luna C18 | 0.1% FA:H2O (A), 0.1% FA:ACN (B) | flow rate: 0.4 mL/min | DAD, 280, 320, 365 nm; |
| [ |
| Luteolin 6-glucoside | ||||||
| Luteolin 8 | ||||||
| Luteolin 7-glucoside | ||||||
| Luteolin 6-glucosie | XBridge C18 | 0.3% FA:H2O (A), MeOH (B) | injection volume: 1 μL; | MS/MS; ESI-MS |
| [ |
| Luteolin 7-glucoside | ||||||
| Luteolin | Symmetry C18 | 0.1% FA:H2O (A), 0.1% FA:ACN (B) | flow rate: 1.0 mL/min; | DAD-ESI-MS; |
| [ |
| Luteolin glucuronyl-hexoside | ||||||
| Luteolin 7-pentosyl-hexoside | ||||||
| Luteolin 7-rutinoside | ||||||
| Luteolin 7-glucoside | ||||||
| Luteolin 7-glucuronide | ||||||
| Luteolin glucoside | ||||||
| Luteolin 7-malonyl-6’’-glucoside | ||||||
| Luteolin 7-acetyl-6’’-glucoside | ||||||
| Luteolin 7-dihexoside | ||||||
| Luteolin | Acquity BEH C18 | 0.1% FA:H2O (A), 0.1% FA:ACN (B) | flow rate: 0.3 mL/ min; | QTOF-MS/MS |
| [ |
| Luteolin7-glucuronide | ||||||
| Luteolin hexoside | Zorbax SB C18 | 0.5% FA:H2O (A), ACN (B) | injection volume: 5 μL; | MS/MS |
| [ |
| Luteolin hexoside | Hypersil gold C18 | 1% FA:H2O (A), 0.1% FA:ACN (B) | flow rate: 1 mL/min | MS/MS |
| [ |
| Luteolin hexosyl-deoxy-hexose | ||||||
| Luteolin dihexoside | Spherisorb S3 ODS-2 C18 | 0.1% FA:H2O (A), | flow rate: 0.5 mL/min; | DAD-ESI-MS/MS |
| [ |
| Luteolin pentosyl-hexoside | ||||||
| Luteolin 7-glucoside | ||||||
| Luteolin malonyl-hexoside | ||||||
| Luteolin | Zorbax SB C18 | 0.1% FA:AFNH4 (A), | injection volume: 1 mL; | ESI-MS/MS |
| [ |
| Luteolin 8-glucoside | ||||||
| Luteolin 5-glucopyranoside |
Abbreviations: AcOH, acetic acid; ACN, acetonitrile; AFNH4, ammonium formate; DAD-ESI-MS, diode array detector combined with electrospray ionization and mass spectrometry; DAD, diode array detector; DAD-ESI-MS/MS, diode array detector combined with electrospray ionization and tandem mass spectrometry; ESI, electrospray ionization; ESI-MS, electrospray ionization combined with mass spectrometry; FA, formic acid; MeOH, methanol; MS/MS, tandem mass spectrometry; PDA-MS, pulsed amperometric detection combined with mass spectrometry; QTOF, quadrupole time-of-flight; TQMS, triple quadrupole mass spectrometer.
Gas chromatography in the analysis of luteolin and its derivatives.
| Luteolin Derivative | Column | Derivatization | Conditions | Detection | Analyzed Species | Ref. |
|---|---|---|---|---|---|---|
| Luteolin | HP-5-MS | 1% TMCS:BSTFA | carrier gas: He; | APCI-TOF-MS | Fruits of various olives species ( | [ |
| Capillary column Supelco SPBM-5 | two- and three-phase transfer catalysis (PTC), methyl iodide | carrier gas: He; | MS |
| [ | |
| non-polar RSL 200 BP | 0.2 M trimethylaniline hydroxide (TMAH):H2O-free MeOH | carrier gas: N2; | FID | different samples form AFRC Institute of Plant Science Research and John Innes Institute, Norwich, U.K. | [ | |
| Py:HMDS:TMCS | ||||||
| BPX5 | Py:BSTFA:TMCS) | carrier gas: He; | QMS | Propolis, | [ | |
| Capillary column Low-bleed CP-Sil 8 CB-MS | TMCS (100 μL), | carrier gas: He; | MS |
| [ | |
| Quartz capillary column | Py:BSTFA | carrier gas: He;injector temperature 220 °C; | MS |
| [ | |
| Luteolin 7,3’,4’-trimethyl | Capillary column Permabond OV-1 | --- | carrier gas: N2, He; | FID |
| [ |
| Capillary column OV-1 | --- | MS |
Abbreviations: Py, pyridine, BSTFA, N,O-bis(trimethylsilyl)trifluoroacetamide; TMS, trimethylsily; HMDS, hexamethyldisilazane; TMCS, trimethylchlorosilane; APCI-TOF-MS, atmospheric pressure chemical ionization combined with quadrupole – time of flight mass spectrometry; FID, flame ionization detector; QMS, quadrupole mass spectrometry.
Counter-current chromatography, as a preparative technique in the separation of luteolin derivatives.
| Luteolin Derivative | Solvent System | Conditions | Detection | Analyzed Species | Ref. |
|---|---|---|---|---|---|
| Luteolin 6-glucoside | EtOAc:BuOH:H2O | rotation speed: 800 rpm; | UV-VIS, 254 nm; |
| [ |
| Luteolin 7-glucoside | EtOAc:EtOH:AcOH:H2O | rotation speed: 800 rpm; | UV, 254 nm; |
| [ |
| Luteolin 6,8-dihexoside | Hx:EtOH:H2O | rotation speed: 850 rpm; | TLC; HPLC-UV-HRMS |
| [ |
| Luteolin 8-glucoside | |||||
| Luteolin 6-glucoside | |||||
| Luteolin 7-glucoside |
Abbreviations: AcOH, acetic acid; BuOH, butanol; EtOAc, ethyl acetate; EtOH, ethanol; HRMS, high resolution mass spectrometry; Hx, hexane, rpm, revolutions per minute.